• Lumos Pharma Announces Clinical Updates firstwordpharma
    July 21, 2021
    Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announces an update on clinical activities.
PharmaSources Customer Service